ASTH stock icon

Astrana Health
ASTH

$47.64
0.46%

Market Cap: $2.17B

 

About: Astrana Health Inc is a patient-centered, physician-centric integrated population health management company. The company is working to provide coordinated, outcomes-based medical care cost-effectively. It is focused on physicians providing high-quality medical care, population health management, and care coordination for patients, particularly senior patients and patients with multiple chronic conditions. Its operating segment is the healthcare delivery segment.

Employees: 1,800

0
Funds holding %
of 6,686 funds
0
Analysts bullish %
of 5 analysts

Fund manager confidence

Based on 2024 Q2 SEC filings by fund managers ($100M+ AUM)

4,812% more call options, than puts

Call options by funds: $26.3M | Put options by funds: $535K

81% more first-time investments, than exits

New positions opened: 29 | Existing positions closed: 16

38% more repeat investments, than reductions

Existing positions increased: 65 | Existing positions reduced: 47

8% more funds holding

Funds holding: 158 [Q1] → 171 (+13) [Q2]

0% more funds holding in top 10

Funds holding in top 10: 1 [Q1] → 1 (+0) [Q2]

0.52% less ownership

Funds ownership: 41.56% [Q1] → 41.04% (-0.52%) [Q2]

4% less capital invested

Capital invested by funds: $967M [Q1] → $932M (-$34.9M) [Q2]

Research analyst outlook

5 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target
$48
1%
upside
Avg. target
$57
19%
upside
High target
$67
41%
upside

5 analyst ratings

positive
100%
neutral
0%
negative
0%
Baird
Michael Ha
82% 1-year accuracy
14 / 17 met price target
41%upside
$67
Outperform
Maintained
15 Aug 2024
Truist Securities
Jailendra Singh
52% 1-year accuracy
17 / 33 met price target
24%upside
$59
Buy
Maintained
9 Aug 2024
Stifel
Craig Jones
86% 1-year accuracy
6 / 7 met price target
26%upside
$60
Buy
Maintained
1 Aug 2024
Truist Securities
Jailendra Singh
52% 1-year accuracy
17 / 33 met price target
5%upside
$50
Buy
Upgraded
11 Jul 2024
Stifel
Craig Jones
86% 1-year accuracy
6 / 7 met price target
1%upside
$48
Buy
Maintained
27 Jun 2024

Financial journalist opinion